https://www.selleckchem.com/pr....oducts/selonsertib-g
The majority of patients with COVID-19 showed mild symptoms. However, approximately 5% of them were critically ill and require intensive care unit admission for advanced life supports. Patients in the intensive care unit were high risk for venous thromboembolism and hemorrhage due to the immobility and anticoagulants used during advanced life supports. The aim of the study was to report the incidence and treatments of the two complications in such patients. Patients with COVID-19 (Group 1) and patients with community-acquire
Like
Comment
Share
